Home › Funds › TPG GP A, LLC › SION
TPG GP A, LLC position in SION
SIONNA THERAPEUTICS INC · Health Care
TPG GP A, LLC reported holding 6,494,962 shares of SION (SIONNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$285.7M, representing 5.87% of its reported portfolio and ranking #5 among its reported holdings. TPG GP A, LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TPG GP A, LLC's SION position evolved
TPG GP A, LLC first disclosed a stake in SION in Q1 2025 at 6,684,962 shares (US$69.9M). The position peaked in Q2 2026 at 6,494,962 shares, worth US$285.7M. Across 6 filings, TPG GP A, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 6,494,962 shares valued at US$285.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 6.68M | $69.92M | New |
| Q2 2025 | 6.74M | $117.03M | Add |
| Q3 2025 | 6.74M | $198.37M | Hold |
| Q4 2025 | 6.74M | $277.49M | Hold |
| Q1 2026 | 6.49M | $260.38M | Reduce |
| Q2 2026 | 6.49M | $285.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SION and 13F data
SION (SIONNA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M), ORBIMED ADVISORS LLC (US$112.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SION
- RA CAPITAL MANAGEMENT, L.P. 9.91M sh · $435.72M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 3.00M sh · $131.78M · Q2 2026
- ORBIMED ADVISORS LLC 2.56M sh · $112.43M · Q2 2026
- Enavate Sciences GP, LLC 2.48M sh · $109.01M · Q2 2026
- PERCEPTIVE ADVISORS LLC 905.00K sh · $39.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 680.92K sh · $29.95M · Q2 2026
- Siren, L.L.C. 610.51K sh · $26.86M · Q2 2026
- Casdin Capital 400.00K sh · $17.60M · Q2 2026
- Kalehua Capital Management LLC 197.07K sh · $8.67M · Q2 2026
- Sofinnova Investments, Inc. 144.43K sh · $6.35M · Q2 2026
- GordonMD Global Investments LP 136.00K sh · $5.98M · Q2 2026
- Sio Capital Management, LLC 127.81K sh · $5.62M · Q2 2026
More on TPG GP A, LLC
FAQ
How long has TPG GP A, LLC held SION?
TPG GP A, LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is TPG GP A, LLC's current position in SION?
As of Q2 2026, TPG GP A, LLC holds 6.49M shares of SION (SIONNA THERAPEUTICS INC), valued at $285.71M, representing 5.87% of its reported portfolio and ranking #5.
Has TPG GP A, LLC been buying or selling SION?
In the latest 13F filing (Q2 2026), TPG GP A, LLC held unchanged its position in SION. The position peaked in Q2 2026 at 6.49M shares.
Which other funds hold SION?
Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, ORBIMED ADVISORS LLC, among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.